NCT06479018View on ClinicalTrials.gov

Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

January 10, 2025

Study Completion Date

January 10, 2026

Conditions
Bullous Pemphigoid
Interventions
BIOLOGICAL

Blood sampling

Venous blood sampling will be carried out for each patient included in the study.

BIOLOGICAL

Liquid bubble sampling

Liquid bubble sampling will be carried out for each patients with Bullous Pemphigoid included in the study.

PROCEDURE

Cutaneous biopsy

At least the first cutaneous biopsy will be carried out for each patients with Bullous Pemphigoid included in the study.

Trial Locations (1)

51092

RECRUITING

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER